
Thai N. Pham
Examiner (ID: 13930, Phone: (571)270-5518 , Office: P/2844 )
| Most Active Art Unit | 2844 |
| Art Unit(s) | 2821, 4134, 2844 |
| Total Applications | 1320 |
| Issued Applications | 1049 |
| Pending Applications | 93 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5821267
[patent_doc_number] => 20060025580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Novel human estrogen receptor beta'
[patent_app_type] => utility
[patent_app_number] => 11/026800
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7733
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025580.pdf
[firstpage_image] =>[orig_patent_app_number] => 11026800
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/026800 | Novel human estrogen receptor beta | Dec 29, 2004 | Abandoned |
Array
(
[id] => 566952
[patent_doc_number] => 07462459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'LAT1 transporters expressed in blood brain barrier cells'
[patent_app_type] => utility
[patent_app_number] => 11/027767
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18406
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462459.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027767
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027767 | LAT1 transporters expressed in blood brain barrier cells | Dec 29, 2004 | Issued |
Array
(
[id] => 577883
[patent_doc_number] => 07452680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'MCT1 transporters expressed in blood brain barrier cells'
[patent_app_type] => utility
[patent_app_number] => 11/026545
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17242
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11026545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/026545 | MCT1 transporters expressed in blood brain barrier cells | Dec 29, 2004 | Issued |
Array
(
[id] => 6984127
[patent_doc_number] => 20050154197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/994727
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23270
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20050154197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994727 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Nov 22, 2004 | Abandoned |
Array
(
[id] => 7111068
[patent_doc_number] => 20050208523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 10/991287
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 62504
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991287 | Compositions and methods for the diagnosis and treatment of tumor | Nov 16, 2004 | Abandoned |
Array
(
[id] => 7145293
[patent_doc_number] => 20050119182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof'
[patent_app_type] => utility
[patent_app_number] => 10/980560
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24077
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980560 | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof | Nov 1, 2004 | Issued |
Array
(
[id] => 7177997
[patent_doc_number] => 20050123961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Human G-protein coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 10/968990
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16284
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10968990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/968990 | Human G-protein coupled receptors | Oct 20, 2004 | Abandoned |
Array
(
[id] => 6925838
[patent_doc_number] => 20050239093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Toll-like receptor'
[patent_app_type] => utility
[patent_app_number] => 10/938740
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9249
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938740 | Toll-like receptor | Sep 9, 2004 | Abandoned |
Array
(
[id] => 7097773
[patent_doc_number] => 20050130232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Methods of screening for compounds that modulate hormone receptor activity'
[patent_app_type] => utility
[patent_app_number] => 10/922339
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27548
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10922339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/922339 | Methods of screening for compounds that modulate hormone receptor activity | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7161578
[patent_doc_number] => 20050084935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/897360
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 186009
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10897360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897360 | PRO526 nucleic acids | Jul 20, 2004 | Issued |
Array
(
[id] => 7345436
[patent_doc_number] => 20040247595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/887932
[patent_app_country] => US
[patent_app_date] => 2004-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 119
[patent_no_of_words] => 23967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247595.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887932 | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | Jul 11, 2004 | Abandoned |
Array
(
[id] => 7161015
[patent_doc_number] => 20050084839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Method for selecting oocytes by using a response to LPA stimulation'
[patent_app_type] => utility
[patent_app_number] => 10/876551
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7466
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876551
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876551 | Method for selecting oocytes by using a response to LPA stimulation | Jun 27, 2004 | Abandoned |
Array
(
[id] => 5672472
[patent_doc_number] => 20060177826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Method of producing recombinant dna molecules'
[patent_app_type] => utility
[patent_app_number] => 10/561743
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13750
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561743 | Method of producing recombinant DNA molecules | Jun 17, 2004 | Issued |
Array
(
[id] => 498079
[patent_doc_number] => 07208579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'IL4 receptor antagonists for horse, dog and cat'
[patent_app_type] => utility
[patent_app_number] => 10/857673
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 9712
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857673 | IL4 receptor antagonists for horse, dog and cat | May 27, 2004 | Issued |
Array
(
[id] => 7201945
[patent_doc_number] => 20050165225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Novel cytokine isolated from an insect'
[patent_app_type] => utility
[patent_app_number] => 10/849783
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3291
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10849783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/849783 | Novel cytokine isolated from an insect | May 20, 2004 | Abandoned |
Array
(
[id] => 7275653
[patent_doc_number] => 20040235104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Human SEF molecule and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/842006
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32136
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842006 | Human SEF molecule and uses therefor | May 6, 2004 | Abandoned |
Array
(
[id] => 7343394
[patent_doc_number] => 20040191791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Novel mutation'
[patent_app_type] => new
[patent_app_number] => 10/477272
[patent_app_country] => US
[patent_app_date] => 2004-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10289
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477272 | Novel mutation | May 4, 2004 | Abandoned |
Array
(
[id] => 5699602
[patent_doc_number] => 20060216286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Novel screening method'
[patent_app_type] => utility
[patent_app_number] => 10/552014
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 44751
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552014 | Novel screening method | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7348425
[patent_doc_number] => 20040248249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/481698
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51414
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481698 | Secreted proteins | Dec 21, 2003 | Abandoned |
Array
(
[id] => 7347944
[patent_doc_number] => 20040248154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Novel human estrogen receptor-beta'
[patent_app_type] => new
[patent_app_number] => 10/745379
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7806
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10745379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/745379 | Novel human estrogen receptor-beta | Dec 21, 2003 | Abandoned |